Abstract
Background/Aim: Mammalian target of rapamycin (mTOR) inhibitors represent the standard of care for metastatic renal cell carcinoma (RCC). However, tre......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
